These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38354516)

  • 1. Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
    Seki N; Tsujimoto H; Tanemura S; Ishigaki S; Takei H; Sugahara K; Yoshimoto K; Akiyama M; Kaneko Y; Chiba K; Takeuchi T
    Cytokine; 2024 Apr; 176():156534. PubMed ID: 38354516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
    Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
    Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
    Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis.
    Zhou Y; Hou W; Xu K; Han D; Jiang C; Mou K; Li Y; Meng L; Lu S
    Hum Immunol; 2015 Jan; 76(1):22-9. PubMed ID: 25500255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.
    Krasimirova E; Velikova T; Ivanova-Todorova E; Tumangelova-Yuzeir K; Kalinova D; Boyadzhieva V; Stoilov N; Yoneva T; Rashkov R; Kyurkchiev D
    World J Exp Med; 2017 Aug; 7(3):84-96. PubMed ID: 28890870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
    Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile.
    Papadimitriou TI; Lemmers JMJ; van Caam APM; Vos JL; Vitters EL; Stinissen L; van Leuven SI; Koenders MI; van der Kraan PM; Koenen HJPM; Smeets RL; Nijveldt R; Vonk MC; Thurlings RM
    Rheumatology (Oxford); 2024 Sep; 63(9):2525-2534. PubMed ID: 38552313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Tu J; Jin J; Chen X; Sun L; Cai Z
    Front Immunol; 2022; 13():868983. PubMed ID: 35663995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
    Lei L; Zhong XN; He ZY; Zhao C; Sun XJ
    Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement.
    Nicola S; Rolla G; Bucca C; Geronazzo G; Ridolfi I; Ferraris A; Fusaro E; Peroni CL; Dughera L; Brussino L
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th17 cell-derived miR-155-5p modulates interleukin-17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis.
    Han L; Lv Q; Guo K; Li L; Zhang H; Bian H
    J Clin Lab Anal; 2022 Jun; 36(6):e24489. PubMed ID: 35545753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
    Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
    Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
    Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
    Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis.
    Corrado A; Rotondo C; Sanpaolo ER; Altomare A; Maruotti N; Cici D; Cantatore FP
    Int J Med Sci; 2022; 19(5):867-877. PubMed ID: 35693738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.